Life Plus' Shape Plus, Endogen supplement ads referred to FTC by NAD.
This article was originally published in The Tan Sheet
LIFE PLUS' ADS FOR SHAPE PLUS AND ENDOGEN REFERRED TO FTC after the company declined to provide supporting documentation requested by the National Advertising Division of the Council of Better Business Bureaus. NAD said in a case report that it "concluded" that Life Plus "has refused to participate in the self-regulatory process" and therefore the watchdog group forwarded the ads in question and its file on the matter to the Federal Trade Commission. The ad claims related to weight loss.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC